Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-survey

NCT05765890 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT05765890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05765890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-survey
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
March 24, 2023
Completion date
September 12, 2023
Enrollment
675 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic fatty liver disease (masld), non-alcoholic steatohepatitis (mash)